ILOTYCIN Drug Patent Profile
✉ Email this page to a colleague
When do Ilotycin patents expire, and when can generic versions of Ilotycin launch?
Ilotycin is a drug marketed by Dista and is included in three NDAs.
The generic ingredient in ILOTYCIN is erythromycin gluceptate. There are one hundred and three drug master file entries for this compound. Additional details are available on the erythromycin gluceptate profile page.
Summary for ILOTYCIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 103 |
| Patent Applications: | 6,502 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ILOTYCIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ILOTYCIN
US Patents and Regulatory Information for ILOTYCIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dista | ILOTYCIN | erythromycin | OINTMENT;OPHTHALMIC | 050368-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Dista | ILOTYCIN GLUCEPTATE | erythromycin gluceptate | INJECTABLE;INJECTION | 050370-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Dista | ILOTYCIN | erythromycin | TABLET, DELAYED RELEASE;ORAL | 061910-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
